Traders should watch for potential downward pressure on the stock, especially if additional insiders sell. The concentration of sales among C-suite executives, including the CEO, suggests possible lack of confidence despite non-cash option exercises being routine.
INSM drugs
INSM drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 30 $153.32entry
- T+1 · 8mo ago +6.65%α +3.76% · $163.52
- T+5 · 7mo ago +6.33%α +2.03% · $163.03
- T+20 · 7mo ago −11.99%α −24.58% · $134.94
- T+60 · 5mo ago −31.86%α −48.35% · $104.47
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two C-suite executives at INSMED Inc sold shares in early April, generating $4.06M in open-market proceeds. CEO Lewis William also exercised options and sold a small portion of shares for $127K, part of a broader insider selling cluster totaling $4.4M in the last 30 days.
Key Financial Metrics
Key Facts
- Chief Operating Officer Adsett Roger sold 6,700 shares at $163.18 for $1.10M on 2026-04-01
- Chief Legal Officer Smith Michael Alexander sold 19,600 shares at $150.98 for $2.96M on 2026-03-30
- CEO Lewis William exercised options and sold 787 shares for $127,281 on 2026-04-06
- Total open-market insider sales in the 7-day cluster: $4.06M; $4.4M over the past 30 days
- Total insider selling represents 0.012% of the $35.2B market cap, but is concentrated among top executives
Financial Impact
$4.06M in net insider selling over 7 days, with $4.4M in total sales over the past 30 days
Risk Factors
- Perceived lack of confidence from top executives could erode investor sentiment
- Risk of follow-on selling by other insiders or institutions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-INSM-1775680923566 |
Track record
24 reports on INSM
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +31.86% at T+60 after the Mar 30, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $111.59 Now $122.88 +10.12% settles Nov 27
- Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $94.04 Now $122.88 +30.67% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 3/10 Entry $95.67 Now $122.88 +28.44% settles Nov 17
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $103.83 to $112.58 Now $122.88 +18.35% ▲ +8.43% +10.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 4/10 Entry $125.08 to $120.00 Now $122.88 −1.76% ▼ −4.06% −4.19% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $126.33 to $129.41 Now $122.88 −2.73% ▲ +2.44% +4.19% vs SPY
- Aug 6, 202614w ago 8-K Bullish 8/10 Entry $132.55 to $126.68 Now $122.88 −7.30% ▼ −4.43% −5.03% vs SPY
- Jul 24, 202616w ago Institutional Cluster Neutral 4/10 Entry $106.92 to $125.77 Now $122.88 +14.93% ▲ +17.63% +14.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers